Market Cap 177.91M
Revenue (ttm) 69.56M
Net Income (ttm) -240.05M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -345.10%
Debt to Equity Ratio -0.66
Volume 275,700
Avg Vol 488,654
Day's Range N/A - N/A
Shares Out 96.69M
Stochastic %K 85%
Beta 1.51
Analysts Strong Sell
Price Target $8.80

Latest News on ADCT

ADC Therapeutics SA (ADCT) Q3 2024 Earnings Call Transcript

Nov 9, 2024, 11:01 AM EST - 4 months ago

ADC Therapeutics SA (ADCT) Q3 2024 Earnings Call Transcript


ADC Therapeutics to Present at November Investor Conferences

Nov 4, 2024, 7:15 AM EST - 4 months ago

ADC Therapeutics to Present at November Investor Conferences


ADC Therapeutics to Present at Upcoming Investor Conferences

Sep 3, 2024, 7:15 AM EDT - 6 months ago

ADC Therapeutics to Present at Upcoming Investor Conferences


ADC Therapeutics SA (ADCT) Q2 2024 Earnings Call Transcript

Aug 11, 2024, 9:26 AM EDT - 7 months ago

ADC Therapeutics SA (ADCT) Q2 2024 Earnings Call Transcript


ADC Therapeutics SA (ADCT) Q1 2024 Earnings Call Transcript

May 6, 2024, 11:04 AM EDT - 11 months ago

ADC Therapeutics SA (ADCT) Q1 2024 Earnings Call Transcript


ADC Therapeutics SA (ADCT) Q4 2023 Earnings Call Transcript

Mar 13, 2024, 1:24 PM EDT - 1 year ago

ADC Therapeutics SA (ADCT) Q4 2023 Earnings Call Transcript


ADC Therapeutics Provides Business Updates

Jan 4, 2024, 7:00 AM EST - 1 year ago

ADC Therapeutics Provides Business Updates


ADC Therapeutics: Navigating A Swirling Drain

Dec 1, 2023, 5:42 PM EST - 1 year ago

ADC Therapeutics: Navigating A Swirling Drain


ADC Therapeutics SA (ADCT) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 4:23 PM EST - 1 year ago

ADC Therapeutics SA (ADCT) Q3 2023 Earnings Call Transcript